Pharma Pulse 4/2/25: Financial Barrier to GLP-1s, The Future of Healthcare is Digital & more
The latest news for pharma industry insiders.
The Financial Barrier to GLP-1s
Colin Banas, MD, DrFirst’s chief medical officer, discusses the challenges that many Americans face regarding the affordability of GLP-1 drugs.
AMCP Keynote Speakder Vin Gupta Says Future of Healthcare is Digital | AMCP Annual 2025
Digital solutions are needed in healthcare now so that more patients can get the access that they need, according to Vin Gupta, MD, MPA, former chief medical officer of Amazon Pharmacy and a leading health policy expert.
markets.
Pharma Industry Braces for Tariffs
Jim Tananbaum, MD and the Founder and CEO of Foresite Capital, a US-focused health-care investment firm says the sector is ripe for transformation thanks to advances in AI, gene editing and new category-killers in areas like pain management and weight loss. He joined Bloomberg Open Interest to lay out his vision, and how he's investing as President Trump's tariff loom large over the pharma industry.
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
Johnson & Johnson announced that following the approval of its pending acquisition of Intra-Cellular Therapies, Inc. by Intra-Cellular Therapies’ shareholders on March 27, 2025, Johnson & Johnson intends to complete its acquisition of Intra-Cellular Therapies on or around April 2, 2025.
Petauri stands ready to optimize market access for oncology therapies based on our extensive subject matter expertise and deep understanding of the many complexities faced by innovators. Please read more in this enlightening article from Shana Gunderson Hua, PharmD, Nancy Pham, and Pete Vaccaro and thanks to Pharmaceutical Executive for featuring this important information!
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs
